We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $1.54M invested in Interpace Biosciences, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
48% less capital invested
Capital invested by funds: $2.98M → $1.54M (-$1.44M)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$4.79K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$2.78K |
| 3 |
Renaissance Technologies
New York
|
+$1.36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$803 |
